Sanwells <9229> is showing a stop-limit sell indication. They announced the submission of an approval application regarding the extension of the deadline for the semi-annual report. In response to reports of fraudulent medical fee claims, a special investigation committee has been established to conduct an inquiry, but it seems unlikely that the investigation will be completed by the deadline. While there were reports of consideration for an extension request, it has led to a stronger sense of uncertainty about the future. Additionally, the interim dividends that were originally planned to be 9 yen have been canceled, and the year-end dividends are also undecided.